Skip to main content

Table 3 Univariate analysis of volumetric parameter cut-off values compared to survival outcomes

From: The effect of tumor volume and its change on survival in stage III non-small cell lung cancer treated with definitive concurrent chemoradiotherapy

Variable*

 

n

3Y LRPFS (%)

p

3Y PFS (%)

p

3Y OS (%)

p

Sex

Male

137

41.6

0.251

22.9

0.589

36.6

0.017

 

Female

20

63.3

 

23.8

 

55.0

 

Age

≤ 60 y

65

41.3

0.563

20.5

0.444

35.5

0.307

 

> 60 y

92

47.9

 

25.0

 

37.1

 

ECOG

0

39

32.6

0.611

15.0

0.318

34.4

0.721

 

1-2

118

47.8

 

25.5

 

36.8

 

Histology

SqCC

86

36.0

0.048

24.0

0.517

32.0

0.151

 

Others

71

56.3

 

19.2

 

41.8

 
 

ADC

52

52.5

0.110

19.2

0.596

45.0

0.335

 

Others

105

40.5

 

24.9

 

34.6

 

T stage

1-2

79

56.4

0.034

25.2

0.281

43.8

0.106

 

3-4

78

33.8

 

20.7

 

28.7

 

N stage

0-2

81

49.4

0.448

29.2

0.108

37.0

0.686

 

3

76

39.5

 

17.0

 

35.6

 

Stage

IIIA

49

56.5

0.084

33.1

0.041

42.0

0.705

 

IIIB

108

39.8

 

18.6

 

33.7

 

GTVpre

(Continuous)

(95% CI)

(1.001)

(0.330)

(1.003)

(<0.001)

(1.001)

(0.019)

  

(HR)

(0.999–1.002)

 

(1.002–1.004)

 

(1.000–1.002)

 
 

≤ 50 cm3

33

75.0

0.001

42.5

0.001

65.7

< 0.001

 

> 50 cm3

124

34.8

 

17.1

 

28.4

 

GTVpost

(Continuous)

(95% CI)

(1.004)

(0.189)

(1.015)

(<0.001)

(1.006)

(0.008)

  

(HR)

(0.998–1.010)

 

(1.008–1.021)

 

(1.002–1.011)

 
 

≤ 20 cm3

68

53.3

0.165

32.4

0.004

43.2

0.015

 

> 20 cm3

89

36.7

 

15.5

 

31.0

 

VRR

(Continuous)

(95% CI)

(1.011)

(0.126)

(1.008)

(0.139)

(1.013)

(0.028)

  

(HR)

(0.997–1.025)

 

(0.997–1.020)

 

(1.001–1.025)

 
 

≤ 50%

21

68.2

0.042

39.6

0.054

64.6

0.004

 

>50%

136

40.6

 

20.2

 

32.2

 
  1. Abbreviations: ADC Adenocarcinoma, CI Confidence interval, ECOG Eastern Cooperative Oncology Group, GTV pre Initial gross tumor volume, GTV post Follow-up gross tumor volume, HR Harzard ratio, LRPFS locoregional progression-free survival rate, OS Overall survival rate, SqCC Squamous cell carcinoma, VRR Reduction ratio of gross tumor volume.
  2. *All variables are categorical, unless being noted as “continuous”.
  3. The log-rank test and the Cox proportional hazards model were used for categorical and continuous variables, respectively.